GlassScriptPhysician profile
David W Frazier
NPI 1114076395
$57,884.23
in general payments reported to CMS, 2019-2025
36 companies · $3,046 in 2025
The $3,046 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $1,697 · 2021: $4,584 · 2022: $6,987 · 2023: $13K · 2024: $16K · 2025: $3,046.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $15K · Consulting Fee: $9,600 · Food and Beverage: $7,327 · Education: $43.93.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $14,979.98 |
| Consulting Fee | $9,600.00 |
| Food and Beverage | $7,326.89 |
| Education | $43.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $46,174.01 | 2019-2025 | Selectra, Solia, Edora 8 Dr-T |
| Abbott Laboratories | $2,724.36 | 2019-2025 | Ensite, Cool Point, Tacticath Ablation Catheter, Sensor Enabled |
| Medtronic Vascular, INC. | $2,575.73 | 2019-2020 | |
| Boston Scientific Corporation | $1,336.28 | 2019-2025 | Farapulse, Watchman Access System, Resonate El Icd Vr |
| Janssen Pharmaceuticals, INC | $879.93 | 2019-2024 | Xarelto |
| Sanofi-Aventis U.S. LLC | $797.24 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $722.39 | 2019-2024 | Camzyos, Eliquis |
| Medtronic, INC. | $433.91 | 2021-2025 | Affera Mapping System, Pulseselect |
| Atricure, INC. | $301.96 | 2021-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Pfizer INC. | $290.18 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $237.11 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $155.71 | 2019-2020 | |
| Nuvasive, INC. | $147.32 | 2021 | |
| Lundbeck LLC | $133.44 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $128.56 | 2019-2024 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Infobionic, INC | $119.79 | 2021-2023 | Mome Kardia |
| Amarin Pharma, INC. | $101.10 | 2019-2021 | |
| Cardiva Medical, INC. | $84.08 | 2020-2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Hikma Pharmaceuticals USA | $76.77 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $67.24 | 2019-2023 | Livalo |
| Lexicon Pharmaceuticals, INC. | $65.57 | 2024 | |
| Elutia, INC. | $57.83 | 2019-2024 | Ecm Patch,Pouch |
| Altathera Pharmaceuticals LLC | $35.96 | 2021-2025 | Sotalol Hydrochloride |
| Astrazeneca Pharmaceuticals LP | $29.73 | 2020 | |
| Esperion Therapeutics, INC. | $23.47 | 2021 | |
| Biosense Webster, INC. | $22.73 | 2019 | |
| Scpharmaceuticals INC. | $21.62 | 2024 | |
| Kestra Medical Technology Services, INC. | $18.93 | 2025 | Assure Wcd |
| Philips North America LLC | $18.57 | 2022 | |
| Medicomp INC | $18.40 | 2024 | Telepatch Cardiac Monitor |
| Baxter Healthcare | $16.25 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Irhythm Technologies, INC. | $15.40 | 2020 | |
| G Medical Diagnostic Services, INC. | $15.35 | 2022 | |
| Arbor Pharmaceuticals, INC. | $13.67 | 2020 | |
| Bardy Diagnostics, INC. | $12.36 | 2022 | |
| Merck Sharp & Dohme LLC | $11.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Frazier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.